| Status: | Phase 2 |
| Entry Type: | Antibody |
| Molecule Category: | UNKNOWN |
| UNII: | 2NHW9AKY9C |
Indications
| Mesh Heading | Maximum Phase | Reference |
|---|---|---|
| Lupus Erythematosus, Systemic | Phase 2 | ClinicalTrials |
| Crohn Disease | Phase 2 | ClinicalTrials |
Cross References
| Resources | Reference |
|---|---|
| ChEMBL | CHEMBL2109613 |
| FDA SRS | 2NHW9AKY9C |
CONTENTS